SPECCHIA, Giorgina
 Distribuzione geografica
Continente #
NA - Nord America 22.900
AS - Asia 7.774
EU - Europa 7.228
SA - Sud America 2.108
AF - Africa 345
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 40.374
Nazione #
US - Stati Uniti d'America 22.624
SG - Singapore 3.330
DE - Germania 2.014
CN - Cina 1.992
BR - Brasile 1.815
RU - Federazione Russa 1.196
HK - Hong Kong 1.146
SE - Svezia 1.098
IT - Italia 803
GB - Regno Unito 604
VN - Vietnam 519
FI - Finlandia 442
UA - Ucraina 426
FR - Francia 192
IN - India 187
CI - Costa d'Avorio 167
CA - Canada 137
AR - Argentina 116
BD - Bangladesh 91
ID - Indonesia 91
MX - Messico 89
PL - Polonia 77
BE - Belgio 72
ZA - Sudafrica 69
IE - Irlanda 67
IQ - Iraq 55
TR - Turchia 55
JP - Giappone 53
NL - Olanda 41
ES - Italia 38
EC - Ecuador 35
VE - Venezuela 34
AT - Austria 32
UZ - Uzbekistan 32
CZ - Repubblica Ceca 29
MA - Marocco 26
PY - Paraguay 25
SA - Arabia Saudita 25
CO - Colombia 24
LT - Lituania 24
KR - Corea 22
PK - Pakistan 19
CL - Cile 18
JO - Giordania 18
IR - Iran 16
TN - Tunisia 16
UY - Uruguay 16
KE - Kenya 14
NP - Nepal 14
OM - Oman 14
PE - Perù 14
RO - Romania 14
IL - Israele 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
JM - Giamaica 11
KZ - Kazakistan 11
ET - Etiopia 10
AU - Australia 9
DZ - Algeria 9
TH - Thailandia 8
AZ - Azerbaigian 7
BY - Bielorussia 7
CH - Svizzera 7
BO - Bolivia 6
EU - Europa 6
HN - Honduras 6
PA - Panama 6
TW - Taiwan 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
RS - Serbia 5
SN - Senegal 5
BB - Barbados 4
BH - Bahrain 4
EE - Estonia 4
GE - Georgia 4
GT - Guatemala 4
HU - Ungheria 4
LB - Libano 4
MY - Malesia 4
PH - Filippine 4
TT - Trinidad e Tobago 4
AO - Angola 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
DK - Danimarca 3
LV - Lettonia 3
MD - Moldavia 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
GF - Guiana Francese 2
GY - Guiana 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
ML - Mali 2
MT - Malta 2
NI - Nicaragua 2
Totale 40.334
Città #
Fairfield 3.138
Ashburn 2.281
Woodbridge 2.046
Singapore 1.723
Chandler 1.570
Houston 1.568
Seattle 1.331
Hong Kong 1.140
Cambridge 1.130
Wilmington 1.030
Ann Arbor 987
Jacksonville 982
Nyköping 853
Beijing 598
New York 495
Lawrence 375
Roxbury 375
Los Angeles 347
Nanjing 290
Bari 259
Des Moines 250
Dallas 249
Boardman 218
Ho Chi Minh City 178
Munich 171
Abidjan 166
Princeton 164
San Diego 154
São Paulo 152
Brooklyn 148
Inglewood 135
Helsinki 103
Hanoi 102
Buffalo 99
Santa Clara 96
Moscow 94
Shenyang 92
Hebei 89
Nanchang 89
London 84
Dearborn 80
Brussels 71
Jiaxing 67
Dublin 62
Tianjin 62
Jakarta 61
Redwood City 61
Chicago 60
Changsha 59
Rio de Janeiro 57
Warsaw 57
Falkenstein 56
Pune 54
Denver 52
Chennai 47
Johannesburg 45
Montreal 44
Paris 44
Council Bluffs 43
Frankfurt am Main 43
Turku 43
Belo Horizonte 40
Tokyo 40
Guangzhou 39
Atlanta 38
Dong Ket 37
Nuremberg 37
The Dalles 36
Rome 35
Columbus 34
Brasília 32
San Francisco 32
Toronto 32
Curitiba 31
Marseille 31
Shanghai 31
Tashkent 31
Mexico City 29
Boston 28
Milan 27
Stockholm 27
Jinan 26
Orem 26
Phoenix 26
Porto Alegre 26
Dhaka 25
Baghdad 24
Poplar 24
Ankara 23
Norwalk 23
Campinas 22
Salvador 22
San Jose 22
Hefei 20
Falls Church 19
Haiphong 19
Amsterdam 18
Manchester 18
Mumbai 18
Brno 17
Totale 27.604
Nome #
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 225
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. 223
A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome 209
Monosomal karyotype in myeloid neoplasias: a literature review 199
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia. 196
A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11) 192
Isolation and characterization of neural stem cells from dystrophic mdx mouse 191
Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients 189
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 187
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 182
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 181
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 178
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 177
5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications. 176
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 176
Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia 174
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 174
A fractal analysis of the spatial distribution of tumoral mast cells in lymph nodes and bone marrow 173
Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9) 172
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 169
Molecular cytogenetic study of instability at 1q21∼q32 in adult acute lymphoblastic leukemia 168
Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology. 168
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese" 167
A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1 165
Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia 165
A novel chromosomal translocation t(3;7)(q26;q21)in myeloid leukemia resulting in overexpression of EVI1 165
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients 162
Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation 161
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3 157
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 156
Decreased TET2 gene expression during chronic myeloid leukemia progression 155
Iron chelation therapy induces hematological response in transfusion dependent patient with myeloid malignancies 154
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 153
t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene 152
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P. 151
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 151
A role of light as potential biomarker for progression of smoldering to symptomatic multiple myeloma 150
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia 149
The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia 149
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma 148
A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene. 148
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? 146
Pericentric chromosome 8 inversion associated with the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases 145
Non-treatment-related chronic myeloid leukemia as a second malignancy 145
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme 145
Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes 144
"Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia 143
A novel translocation t(14;15)(q32;q24) bearing deletion on der(14) in Philadelphia-positive chronic myeloid leukemia 142
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints 142
Molecular cytogenetic findings supporting the evidence of a biclonal origin in acute myeloid leukemia 140
Vascular Endothelial Growth Factor Serum Levels Are Elevated in Patients with Hereditary Hemorrhagic Telangiectasia 140
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 140
Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma 139
Typhlitis complicating induction therapy in adult acute myeloid leukemia 139
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 139
Impact of bone marrow aspirate tregs on the response rate of younger newly diagnosed acute myeloid leukemia patients 137
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 136
Cardiovascular events and intensity of treatment in polycythemia vera. 136
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 135
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 135
CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: THE REAL LIFE EXPERIENCE OF RETE EMATOLOGICA PUGLIESE (REP) 135
CT-guided needle biopsy performed with modified coaxial technique in the diagnosis of malignant lymphomas 133
A novel translocation t(2;9)(q14;p12) in AML-M2 with an uncommon phenotype: myeloperoxidase-positive and myeloid antigen-negative 133
Skin lesions in chronic myeloid leukemia patients during dasatinib treatment 133
Molecular cytogenetic characterization of a novel additional chromosomal aberration in blast crisis of a PH-positive chronic myeloid leukemia 131
CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds? 131
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 131
Concomitant primary polycythemia vera and follicle center cell non-Hodgkin lymphoma: a case report and review of the literature 130
Differences among young adults, adults, and elderly chronic myeloid leukemia patients. 130
Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements 130
Concomitant tetrasomy 3q and trisomy 18 in CD5(-), CD13(+) chronic lymphocytic leukemia 127
Sclerostin is overexpressed by plasma cells from multiple myeloma patients 127
Acute myeloblastic leukemia with minimal myeloid differentiation featuring a three-way translocation t(8;13;14) 127
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 127
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 126
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. 126
Next-Generation Sequencing in Acute Lymphoblastic Leukemia 126
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 126
Chronic Myeloid Leukemia with Variant t(9;22) Shows Dysregulated Expression of Genes Included in Pivotal Cellular Pathways 125
Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases 125
Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience. 124
Concomitant tetrasomy 3q and trisomy 18 in CD5- CD13+ chronic lymphocytic leukemia 123
Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto 123
Retinal abnormalities in newly diagnosed adult acute myeloid leukemia 123
Autoimmune Myelofibrosis: report of three cases and review of the literature 122
null 122
Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia 121
The Behavior of Cytogenetic/Molecular Markers Associated with JAK2 Mutation Status Before and After Primary Myelofibrosis Progression Supports the Hypothesis of the Leukemic Clone's Independence From the JAK2 Mutation 121
SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia. 121
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 120
ANALYSIS OF PROGNOSTIC FACTORS AND TIME TO FIRST TREATMENT IN YOUNG PATIENTS (<55 YEARS) WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A SINGLE CENTER EXPERIENCE 120
SETBP1 dysregulation in congenital disorders and myeloid neoplasms 118
Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics. 117
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis 117
Analysis of percent identity of IGHV mutation as prognostic factor in CLL patients treated with fludarabine, cyclofosfamide and rituximab: a single centre experience 117
Extramedullary disease in acute promyelocytic leukemia: two-in-one disease. 116
Submicroscopic deletions in an acute myelocytic leukemia case with a four-way t(8;11;16;21) 116
A case of light chain (AL) amyloidosis associated with IgD Multiple Myeloma (MM): clinical features, laboratory findings and outcome 116
MIRN199B downregulation in chronic myeloid leukaemia is associated with deletions on der(9) 115
null 115
Totale 14.671
Categoria #
all - tutte 168.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.491


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.365 0 0 0 0 0 328 310 423 294 504 268 238
2021/20222.686 205 263 26 89 126 258 129 123 207 218 449 593
2022/20234.152 611 496 252 349 480 587 42 462 684 31 76 82
2023/20241.760 160 277 73 88 181 596 32 49 9 62 28 205
2024/20256.614 192 123 538 273 178 576 616 597 299 392 940 1.890
2025/20267.775 1.987 660 987 1.798 1.669 674 0 0 0 0 0 0
Totale 41.267